• No Restatement of Financials: .  There will not be a restatement of any of the Company's financial statements.
  .
• SEC Review: The Company underwent a full review by the SEC, with particular emphasis on accounting issues (March 10, 1998 - August 14, 1998). The Company's registration statements were declared effective on August 14, 1998. Any amendments to prior SEC filings by the Company did not result in any restatement or any change in sales, earnings, assets or equity previously reported by the Company. There is no more further review.
  .
• Fourth Quarter and Fiscal 1999 Performance: As reported (August 19th) by the Company and analysts covering the Company, the Company will recognize revenues, assets, equity and earnings of acquisitions "at closing" as opposed to "effective dates" commencing April 1, 1998. This change was made 3 months earlier than planned in order to have an effective registration statement by August 14th . However, the Company's 10-K will show results with both effective and closing date income recognition to allow shareholders to compare performance with expectations. Fiscal 1999 projections previously announced by analysts have not been changed since the Company was planning to recognize acquisitions at closing effective July 1, 1998.
  .
• Pending Announced Acquisitions: The Company has closed 14 acquisitions since January 1 and only one announced pending acquisition remains to be closed (Oseco Inc.). This acquisition is expected to close within two weeks.
  .
• Future Acquisitions: The Company continues to successfully negotiate for new acquisitions to enhance market share and germplasm. Dr. Thomas expects, "the Company's annualized revenue run rate to reach the $500 million target by December 31, 1998, two years ahead of schedule".
  .
• Shelf Registration Statements: The Company's effective registration statement provides management flexible access to capital when needed to effectively implement the Company's business plan. According to Dr. Thomas, "all shareholders who embrace management's plans to 'build franchise value' should eagerly anticipate additional capital formation, since management will only access capital when business opportunities exceed the cost of capital".
  .
• Continued Growth vs. No Growth: The Company is at a unique stage of development. There are no acquisition candidates which must be acquired to accomplish Company objectives; however, there are acquisition candidates which if acquired would increase shareholder value more than the cost of capital.
  .
• Biotechnology Access: The Company continues to advance several very important negotiations toward a successful conclusion.
  .
• Conference Call: Dr. Thomas will host a conference call at 10 a.m. EST, on August 26, 1998 to answer any questions. Shareholders may call in on 1-800-230-1092. The call will be available on replay by calling 1-800-475- 6701 access code #403509.
  .
• Website Changes: The Company has deleted analyst reports and chairman's updates from its website as a direct result of the SEC registration process. According to Dr. Thomas, "it is unfortunate that management is unable to provide more complete information on the Company to shareholders".

The statements discussed in this press release include forward-looking statements that involve a number of risks and uncertainties. These include the Company's historical lack of profitability, need to manage its growth, intense competition in the seed industry, seasonality of quarterly results, and other risks detailed from time to time in the Company's SEC reports.

N1202